Dermatologist Hair Regrowth: What They Actually Do in 2026

Introduction: What Does a Dermatologist Actually Do for Hair Loss in 2026?

Many men delay seeing a dermatologist about thinning hair because they are unsure what the visit involves. This guide explains that process step by step, walking through what a board-certified dermatologist does, from the first intake question to the final prescription, and why each step matters.

The problem is widespread. More than 80 million men and women in the United States currently deal with hair loss. More than 80% of men and nearly half of women experience significant hair loss during their lifetime, and alopecia affects one in four men by age 30.

Androgenetic alopecia (AGA), commonly called pattern hair loss, causes 95% of hair loss cases in men and about 40% in women. For that reason, most of this guide focuses on pattern loss. It also covers the autoimmune and scarring conditions that require a different approach.

The guide follows the same sequence a dermatologist uses:

• The diagnostic workup
• Classification of the type of hair loss
• The treatment hierarchy, including the 2026 combination-therapy standard and new JAK inhibitors
• A red-flag framework for deciding between telehealth and in-person care

The emotional impact is significant: research summarized in JAMA Dermatology links AGA to depression and lower quality of life, and 78% of women with hair loss report feelings of shame, anxiety, or depression. Men face the same pressures, often without discussing them. A fast, accurate diagnosis is the first step toward regaining control.

Why Early, Accurate Diagnosis Matters More Than Any Product

Hair loss has dozens of possible causes, including AGA, alopecia areata, telogen effluvium, scarring alopecias, nutritional deficiencies, thyroid disorders, and medication-induced shedding. The American Academy of Dermatology (AAD) advises patients to see a board-certified dermatologist because hair loss has so many causes, and “the sooner you find the cause, the better your chance of getting results you want.”

Medications are a frequently overlooked trigger. Before attributing shedding to genetics, a dermatologist must rule out drugs known to cause or worsen telogen effluvium, including:

• ACE-inhibitors and beta-blockers
• Antidepressants, antiepileptics, antipsychotics, and mood stabilizers
• Antifungals and triazoles
• Anticoagulants
• Retinol and retinoids
• Antiretrovirals
• Oral contraceptives
• Dopamine agonists
• Analgesics and anti-inflammatory drugs (NSAIDs)

Realistic expectations also matter. The AAD states that minoxidil can help early hair loss but cannot regrow an entire head of hair. That is not a reason for discouragement, but a reason to act early.

Follicles that have fully miniaturized or scarred respond poorly to any therapy, whether it is prescribed in a clinic or through telehealth. The best results come from treating follicles that are still alive and producing hair.

Inside the Dermatology Visit: The Clinical Hair-Loss Workup

This is the clinical core of a dermatology appointment. The structured approach outlined in the Journal of the American Academy of Dermatology’s “Approach to the Patient with Hair Loss” protocol combines medical and family history, a scalp and hair exam, a pull test, trichoscopy, and, when needed, targeted blood work and biopsy. Any rigorous provider, in person or remote, should follow the same logic.

Step 1: History and Pattern Recognition

The dermatologist starts with questions about:

• Onset speed: gradual over years or sudden over weeks
• Distribution: diffuse, patchy, crown, or hairline
• Family history of pattern baldness
• Recent events: illness, surgery, major stress, or dietary changes
• New medications or hormonal changes

The answers quickly narrow the diagnosis. Gradual, symmetric thinning at the temples and crown in a man with a balding father points strongly to AGA. Sudden, coin-shaped bald patches suggest alopecia areata. Diffuse shedding a few months after a fever or major stressor suggests telogen effluvium.

Step 2: The Pull Test and Physical Scalp Exam

In the pull test, the dermatologist gently tugs a small section of hair and counts how many resting-phase (telogen) hairs come out. This measures how much active shedding is occurring.

The physical exam then checks the scalp for redness, scaling, pustules, or scarring. Any of these findings indicates that the problem may be more than simple pattern loss.

Step 3: Trichoscopy, the Diagnostic Backbone

Trichoscopy is dermoscopy of the scalp, a magnified view of hair shafts and follicle openings. It is now the foundation of hair-loss diagnostics. It shows features that cannot be seen with the naked eye:

• Follicular miniaturization: shrinking hairs of varying thickness, the signature of AGA
• Yellow dots and black dots: associated with alopecia areata
• Exclamation-point hairs: short hairs that taper at the base, a classic alopecia areata finding

Trichoscopy has limits. It does not always provide enough sensitivity and specificity in ambiguous cases, so biopsy remains the gold standard when findings are unclear.

Step 4: Targeted Blood Panels

When the history or exam suggests a cause other than pattern loss, dermatologists order targeted labs such as:

• A thyroid panel
• Ferritin and iron studies
• Hormone panels, particularly for women with suspected PCOS or excess androgens

These tests are not routinely needed for classic male AGA. They become essential when there is diffuse shedding or when systemic symptoms are present.

Step 5: When a Scalp Biopsy Is Required

Biopsy remains the gold standard for definitively diagnosing scarring alopecias. The procedure requires, at minimum, a 4 mm punch biopsy that reaches the fat beneath the skin, performed in the office under local anesthesia. It is a minor procedure, not major surgery.

Dermatologists typically recommend a biopsy when:

• Scarring alopecia is suspected
• The presentation is atypical
• The patient has not responded to standard therapy
• Inflammatory or autoimmune skin disease must be ruled out

Classifying Hair Loss: Why “Hair Loss” Isn’t One Diagnosis

Much consumer content treats hair loss as a single condition. Dermatologists sort it into distinct categories:

The category determines both the treatment and whether telehealth is appropriate. The rest of this guide is organized around that distinction.

The Dermatologist’s Treatment Hierarchy for Pattern Hair Loss (AGA)

For AGA, dermatologists in 2026 follow a defined sequence: first-line FDA-approved medication, then combination therapy, then procedural add-ons. According to the AAD, the two FDA-approved first-line treatments remain topical minoxidil and oral finasteride. Every other option builds on these two.

First-Line: Topical and Oral Minoxidil

Minoxidil is a vasodilator. It prolongs the anagen (growth) phase of the hair cycle and increases follicle size. It is FDA-approved in topical 2% and 5% formulations for both men and women.

Low-dose oral minoxidil is increasingly prescribed off-label. A main reason is adherence. Many men stop using topical minoxidil because it is greasy, takes time to apply twice a day, and interferes with styling. A daily pill removes those obstacles, and consistent use is what produces results.

Finasteride vs. Dutasteride: Comparing DHT Blockers

Dihydrotestosterone (DHT) is the hormone that gradually shrinks genetically sensitive follicles. Both finasteride and dutasteride work by blocking 5-alpha reductase, the enzyme that converts testosterone into DHT.

• Finasteride (1 mg oral, FDA-approved for men in 1997) inhibits the Type II enzyme and reduces DHT by approximately 70%.
• Dutasteride inhibits both Type I and Type II enzymes and reduces DHT by up to 90%. It is used off-label for AGA and is increasingly favored by hair-restoration specialists.

This difference has clinical significance. Blocking both enzyme types suppresses the hormone driving follicle shrinkage more completely, which is why many specialists now choose dutasteride for men who want stronger, more lasting DHT control. As with any DHT blocker, a licensed provider should review the patient’s suitability and discuss possible side effects.

Combination Minoxidil + Dutasteride/Finasteride: The Emerging Gold Standard

Combination therapy is replacing monotherapy as the evidence-based standard. A UK study of 502 patients found that 92.4% achieved stable or improved outcomes over 12 months with oral minoxidil plus finasteride. This combination is now considered the gold standard for non-surgical AGA treatment.

The two drugs address the problem in complementary ways:

1. Minoxidil stimulates follicles to grow.
2. The DHT blocker stops the hormonal process that shrinks them.

Thryve Hair Lab’s compounded 4-in-1 capsule is built on this combination model. It contains minoxidil 2.5 mg and dutasteride 0.5 mg, plus biotin and vitamin D3, and is delivered through telehealth. The formula is detailed below.

Procedural Adjuncts: PRP and Microneedling

When medication alone reaches a plateau, dermatologists may add procedures:

• PRP (platelet-rich plasma): A 2025 systematic review and meta-analysis found activated PRP effective as an in-office treatment. It is typically given as a series of sessions.
• Microneedling: Research cited by the AAD found that after 12 weeks, patients who combined minoxidil with weekly microneedling had significantly more hair growth than those using minoxidil alone. It is a low-cost option that may improve absorption of topical treatments.

These procedures add to first-line therapy. They do not replace it.

The 2026 Breakthrough: JAK Inhibitors for Alopecia Areata

Alopecia areata now has its own class of FDA-approved treatments. Since 2022, the FDA has approved three JAK inhibitors for severe alopecia areata: Olumiant (baricitinib), Litfulo (ritlecitinib), and Leqselvi (deuruxolitinib).

In September 2026, the FDA approved baricitinib for severe alopecia areata in patients aged 12 and older, based on data from the BRAVE-AA-PEDS trial. Baricitinib now joins ritlecitinib as an option for adolescents. JAK inhibitors achieve hair regrowth rates of 23% to 40%, a major improvement for a condition where steroid treatments have historically had poor results.

An important point: JAK inhibitors treat autoimmune alopecia areata. They do not treat pattern hair loss. A man with a receding hairline will not benefit from them, which is another reason accurate diagnosis must come first.

The Clinical Decision Framework: When Telehealth Is Appropriate vs. When an In-Person Dermatologist Is Needed

AAD consumer pages do not address this question, and many direct-to-consumer brands avoid it. The guiding clinical principle is that a straightforward case of male or female pattern hair loss, without systemic disease, red flags, or diffuse shedding suggesting a nutritional or thyroid problem, does not require an in-person exam.

Green Light: Cases Safely Managed via Telehealth

Telehealth is generally appropriate when:

• The patient has classic AGA: gradual, symmetric thinning at the crown, temples, or hairline, with a family history and no scalp abnormalities
• There are no signs of scarring, inflammation, or rapid diffuse shedding
• The patient is a reasonable candidate for first-line or combination therapy (minoxidil plus finasteride or dutasteride) based on symptom history

This is the population for which remote management makes clinical sense. A thorough telehealth intake, including a history questionnaire, photos where requested, and review by a licensed provider, can provide the same diagnostic value as an in-office visit for AGA.

Red Flags: When an In-Person Dermatologist and Possible Biopsy Are Needed

An in-person dermatologist is needed for any of the following:

• Scarring, excessive scaling, or pus drainage: requires prompt in-person evaluation
• Sudden, patchy loss: possible alopecia areata, which may call for JAK inhibitor evaluation or steroid injections into the affected patches
• Rapid, diffuse shedding with systemic symptoms such as fatigue, weight change, or menstrual irregularity: requires blood work for thyroid, iron, or hormonal disease
• Scalp pain, burning, or visible inflammation: common signs of scarring alopecia that require biopsy
• No response after 6 to 12 months of appropriate first-line therapy: may indicate a misdiagnosis that needs biopsy confirmation

In-person dermatologists provide services telehealth cannot: a physical scalp exam, biopsy, treatment for alopecia areata, telogen effluvium, and scarring alopecias, and procedures such as PRP or hair transplant consultations.

How Thryve Translates the Dermatologist’s Gold-Standard Protocol Into Telehealth

Thryve Hair Lab does not position itself as a substitute for diagnosis. It provides the combination therapy dermatologists now consider the gold standard for AGA, in a format suited to men with green-light cases.

The 4-in-1 compounded daily capsule:

The formula uses dutasteride rather than finasteride because of its broader DHT suppression (up to 90% versus about 70%). It follows the same growth-plus-blocker logic supported by the 92.4% outcome study. The capsule was formulated by a medical team that includes board-certified hair surgical specialists and transplant surgeons with decades of hair-restoration experience.

How the process works:

1. A 2 to 3 minute medical questionnaire collects the history a dermatologist would ask about: onset, pattern, family history, and medications.
2. A licensed provider reviews it, typically within one business day, to confirm the patient is an appropriate AGA candidate.
3. Discreet, TSA-compliant blister packs ship by 2-day FedEx.
4. Ongoing subscription care keeps dosing consistent.

Pricing: $67 per month on the 20-week plan or $78 per month on the 12-week plan, with free shipping and no contracts. Buying minoxidil, dutasteride, biotin, and D3 separately costs roughly $135 per month. If the medical team does not approve treatment, the patient receives a full refund. A 1-year satisfaction guarantee provides additional protection.

The safety boundary: Thryve’s model is designed for classic AGA. Patients with red-flag symptoms, such as scarring, patchy loss, scalp inflammation, or systemic symptoms, should see an in-person dermatologist.

What to Realistically Expect: Timelines and Long-Term Management

Hair grows slowly, and results take time:

• 3 to 6 months: visible improvement typically begins
• 9 to 12 months: peak results with consistent combination therapy

As the AAD notes, minoxidil-based therapy can help early hair loss but cannot regrow an entire head of hair. The realistic goal is to stop further loss and restore density in areas where follicles are still active.

Treatment must also continue. Stopping AGA medication typically reverses gains within 6 to 12 months. Managing hair loss is a long-term commitment, not a one-time fix. For this reason, consistent automatic delivery through a subscription is clinically important, not just convenient. Missed refills lead to missed doses, and missed doses lead to lost progress.

Frequently Asked Questions About Dermatologist Hair Regrowth Treatment

Is finasteride or dutasteride better for hair regrowth?
Finasteride blocks one enzyme and reduces DHT by about 70%. Dutasteride blocks two enzymes and reduces DHT by up to 90%. Many specialists prefer dutasteride for stronger suppression, particularly when it is combined with minoxidil.

Is a biopsy required to start hair loss treatment?
Usually not. Biopsy is reserved for suspected scarring alopecia, atypical presentations, or cases that do not respond to treatment. Classic AGA is diagnosed from history and pattern.

Can telehealth really replace a dermatologist visit for hair loss?
For uncomplicated pattern hair loss, yes. When red flags are present, such as scarring, patchy loss, inflammation, or systemic symptoms, an in-person visit is necessary.

What is the difference between alopecia areata and androgenetic alopecia?
Alopecia areata is autoimmune and causes sudden, patchy loss. It is treated with JAK inhibitors or steroid injections. Androgenetic alopecia is genetic and hormonal and causes gradual thinning. It is treated with minoxidil and DHT blockers.

How soon do results appear from combination minoxidil and dutasteride therapy?
Most men notice changes at 3 to 6 months, with peak results at 9 to 12 months of consistent daily use.

Conclusion: Clinical Authority Meets Modern Convenience

Dermatologists diagnose hair loss through a structured workup: history, pull test, trichoscopy, labs when indicated, and biopsy when necessary. They then prescribe a sequence of treatments led by combination minoxidil and dutasteride or finasteride. PRP, microneedling, and JAK inhibitors serve as advanced options for specific cases.

The most important step is identifying the type of hair loss. Classic AGA is common and highly treatable, especially when addressed early.

For men with straightforward pattern loss, Thryve Hair Lab provides access to the same combination approach dermatologists endorse, while directing red-flag cases to in-person specialists. Early action, doctor-guided care, and consistent long-term treatment are what produce lasting results.

Ready to Start a Doctor-Guided Hair Regrowth Plan?

Men experiencing gradual thinning, a receding hairline, or crown loss can complete Thryve Hair Lab’s 2 to 3 minute online medical questionnaire to find out whether they qualify for the 4-in-1 compounded combination therapy.

A licensed provider reviews each submission, typically within one business day. Patients who are not approved receive a full refund. Approved treatment includes a 1-year satisfaction guarantee and arrives in discreet packaging by 2-day shipping.

Thryve offers personalized, doctor-guided treatment based on the clinical standard of care, available without a long wait for an appointment.